SCHEMBL1685494

SCHEMBL1685494

CCCCCC(CCC)N(N)N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.44
PLA2G1B P04054 1/20 0.39
PLA2G2A P14555 1/20 0.39
SPHK1 Q9NYA1 2/20 0.37
LMNA P02545 2/20 0.36
TP53 P04637 2/20 0.35
LAP3 P28838 2/20 0.35
DNM1 Q05193 1/20 0.35
CYP2D6 P10635 2/20 0.34
GMNN O75496 1/20 0.34
POLB P06746 1/20 0.34
THPO P40225 1/20 0.34
MTOR P42345 1/20 0.34
BLM P54132 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
CETP P11597 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6579135 0.98 OPRM1 (0.42) OPRM1PLA2G1BPLA2G2ASPHK1LMNA
SCHEMBL1685493 0.92 ALDH1A1 (0.37) OPRM1PLA2G1BPLA2G2ALMNADNM1
SCHEMBL9761739 0.87 ALDH1A1 (0.40) OPRM1PLA2G1BPLA2G2ALMNADNM1
SCHEMBL532756 0.87 TSHR (0.30)
SCHEMBL8946581 0.83 OPRM1 (0.42) OPRM1PLA2G1BPLA2G2ASPHK1LMNA
SCHEMBL13067518 0.83 OPRM1 (0.42) OPRM1PLA2G1BPLA2G2ASPHK1LMNA
SCHEMBL6545348 0.82 PLA2G1B (0.34) PLA2G1BPLA2G2ADNM1
SCHEMBL6544930 0.81
SCHEMBL16935731 0.78 OPRM1 (0.38) OPRM1PLA2G1BPLA2G2ASPHK1LMNA
SCHEMBL24247877 0.77 OPRM1 (0.40) OPRM1PLA2G1BPLA2G2ALMNADNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4306566-B1 CURABLE RESIN COMPOSITION, CURED PRODUCT AND ADHESIVE ADEKA CORP (JP) 2026-05-06 EP disclosed
US-12590178-B2 Curable resin composition and method for suppressing curing shrinkage of curable resin composition ADEKA CORPORATION (JP) 2026-03-31 US disclosed
EP-4306567-B1 CURABLE RESIN COMPOSITION, CURED PRODUCT, AND ADHESIVE ADEKA CORP (JP) 2025-06-04 EP disclosed
US-12269917-B2 Curable resin composition ADEKA CORPORATION (JP) 2025-04-08 US disclosed
US-20250109324-A1 CURING AGENT FOR EPOXY RESIN, AND ADHESIVE SUNSTAR ENGINEERING INC. (JP) 2025-04-03 US disclosed
US-20250109240-A1 ONE-PACK TYPE EPOXY RESIN COMPOSITION ADEKA CORPORATION (JP) 2025-04-03 US disclosed
WO-2025062839-A1 COMPOUND, EPOXY RESIN, CURABLE COMPOSITION, MATERIAL FOR RECYCLING, CURED ARTICLE, METHOD FOR PRODUCING CURED ARTICLE, METHOD FOR PRODUCING DECOMPOSITION PRODUCT, AND DECOMPOSITION METHOD 株式会社ADEKA 2025-03-27 WO disclosed
WO-2025047655-A1 BLOCK URETHANE MATERIAL, COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND BLOCK URETHANE COMPOUND CONTAINED THEREIN 株式会社ADEKA 2025-03-06 WO disclosed
EP-4491653-A1 ONE-PACK TYPE EPOXY RESIN COMPOSITION ADEKA CORPORATION (JP) 2025-01-15 EP disclosed
US-20250002707-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT, AND ADHESIVE ADEKA CORPORATION (JP) 2025-01-02 US disclosed
CN-101175783-B Radiation-curable aqueous polyurethane dispersions BASF AG (DE) 2011-12-28 CN disclosed
US-20110095453-A1 ONE LIQUID TYPE CYANATE-EPOXY COMPOSITE RESIN COMPOSITION ADEKA CORPORATION (JP) 2011-04-28 US disclosed
CN-101563380-A Microcapsules containing compounds containing carbodiimide groups BASF SE (DE) 2009-10-21 CN disclosed
CN-100526375-C Stabilizer composition for halogen-containing polymers BAERLOCHER GMBH (DE) 2009-08-12 CN disclosed
CN-100519639-C Stabilising composition for halogen-containing polymers BAERLOCHER GMBH (DE) 2009-07-29 CN disclosed
CN-101233077-A Solid salt preparation, the production thereof and its use BAERLOCHER GMBH (DE) 2008-07-30 CN disclosed
CN-101175783-A Radiation-curable aqueous polyurethane dispersions BASF AG (DE) 2008-05-07 CN disclosed
CN-1890282-A Process for preparing miniemulsion block polymers BASF AG (DE) 2007-01-03 CN disclosed
CN-1717441-A Stabilizer composition for halogen-containing polymers BAERLOCHER GMBH (DE) 2006-01-04 CN disclosed
CN-1717442-A Stabilisation composition for halogen-containing polymers BAERLOCHER GMBH (DE) 2006-01-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590178-B2 Curable resin composition and method for suppressing curing shrinkage of curable resin composition SEM1, RER1, JMJD6 OPRM1 717/4885PLA2G1B 1778/4885PLA2G2A 2596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.